Clinical and Experimental Reproductive Medicine

  • 제50권2호
  • /
  • Pages.117-122
  • /
  • 2023
  • /
  • 2233-8233(pISSN)
  • /
  • 2233-8241(eISSN)
대한생식의학회 (The Korean Society for Reproductive Medicine)
권호 표지
DOI QR코드

DOI QR Code

Association between polycystic ovarian morphology and insulin resistance in women with polycystic ovary syndrome

  • Jeong Eun Lee (Department of Obstetrics and Gynecology, Fertility Center of CHA Bundang Medical Center, CHA University) ;
  • Yubin Park (Department of Obstetrics and Gynecology, Inje University Haeundae Paik Hospital) ;
  • Jisoo Lee (Department of Obstetrics and Gynecology, Inje University Haeundae Paik Hospital) ;
  • Sungwook Chun (Department of Obstetrics and Gynecology, Inje University Haeundae Paik Hospital)
  • 투고 : 2022.12.20
  • 심사 : 2023.03.07
  • 발행 : 2023.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: The aim of the present study was to determine whether polycystic ovarian morphology (PCOM) is related to insulin resistance in women with polycystic ovary syndrome (PCOS). Methods: A total of 147 Korean women aged 18 to 35 years and diagnosed with PCOS were included in this study. Fasting blood tests and standard 2-hour 75-g oral glucose tolerance tests were performed for all participants. PCOM-related parameters including total antral follicle count (TFC) and total ovarian volume (TOV) were assessed using transvaginal or transrectal ultrasonography. Correlation analysis was conducted to assess the relationships of TFC and TOV with insulin resistance-related clinical and biochemical parameters using Spearman rank correlation coefficients and linear regression analysis, with partial correlations used to control for the effects of confounding covariates. Results: Fasting insulin levels, low-density lipoprotein levels, and insulin sensitivity assessment indices (ISAIs) were significantly correlated with TFC, but neither postprandial blood glucose levels nor insulin levels were significantly associated with TFC. No insulin resistance-related parameter was significantly correlated with TOV. These results did not change after adjustments for other anthropometric covariates. Fasting insulin and some ISAIs differed significantly between groups categorized by the median TFC value (TFC ≤54 and TFC >54). Conclusion: TFC, but not TOV, was found to be related to fasting insulin resistance-related parameters in women with PCOS.

키워드

참고문헌

  1. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25:544-51. https://doi.org/10.1093/humrep/dep399
  2. Rodriguez-Paris D, Remlinger-Molenda A, Kurzawa R, Glowinska A, Spaczynski R, Rybakowski F, et al. Psychiatric disorders in women with polycystic ovary syndrome. Psychiatr Pol 2019;53:955-66. https://doi.org/10.12740/PP/OnlineFirst/93105
  3. Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update 2011;17:17-33. https://doi.org/10.1093/humupd/dmq032
  4. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers 2016;2:16057.
  5. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 2018;33:1602-18. https://doi.org/10.1093/humrep/dey256
  6. Hong SH, Sung YA, Hong YS, Jeong K, Chung H, Lee H. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2017;87:375-80. https://doi.org/10.1111/cen.13380
  7. Adams JM, Taylor AE, Crowley WF, Hall JE. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 2004;89:4343-50. https://doi.org/10.1210/jc.2003-031600
  8. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 2012;33:981-1030. https://doi.org/10.1210/er.2011-1034
  9. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25. https://doi.org/10.1016/j.fertnstert.2003.10.004
  10. Chae SJ, Kim JJ, Choi YM, Hwang KR, Jee BC, Ku SY, et al. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod 2008;23:1924-31. https://doi.org/10.1093/humrep/den239
  11. Chun S. 1-h Postprandial glucose level is related to the serum anti-Mullerian hormone level in women with polycystic ovary syndrome. Gynecol Endocrinol 2015;31:815-8. https://doi.org/10.3109/09513590.2015.1056143
  12. Park CH, Chun S. Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndrome. Obstet Gynecol Sci 2016;59:498-505. https://doi.org/10.5468/ogs.2016.59.6.498
  13. Kim N, Chun S. Association between the serum estrone-to-estradiol ratio and parameters related to glucose metabolism and insulin resistance in women with polycystic ovary syndrome. Clin Exp Reprod Med 2021;48:374-9. https://doi.org/10.5653/cerm.2021.04553
  14. The Korean Society of Gynecologic Endocrinology. The Korean Society of Gynecologic Endocrinology clinical guideline 2016. The Korean Society of Gynecologic Endocrinology; 2016. p. 27.
  15. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003;9:505-14. https://doi.org/10.1093/humupd/dmg044
  16. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999;84:1897-9. https://doi.org/10.1210/jcem.84.6.5803
  17. De Leo V, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia F. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol 2016;14:38.
  18. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-36. https://doi.org/10.1056/NEJMra041536
  19. Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril 2007;88:1389-95. https://doi.org/10.1016/j.fertnstert.2007.01.032
  20. Shi Y, Gao X, Sun X, Zhang P, Chen Z. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women. Fertil Steril 2008;90:1139-43. https://doi.org/10.1016/j.fertnstert.2007.07.1375
  21. Christ JP, Vanden Brink H, Brooks ED, Pierson RA, Chizen DR, Lujan ME. Ultrasound features of polycystic ovaries relate to degree of reproductive and metabolic disturbance in polycystic ovary syndrome. Fertil Steril 2015;103:787-94. https://doi.org/10.1016/j.fertnstert.2014.12.094
  22. Norman RJ, Hague WM, Masters SC, Wang XJ. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod 1995;10:2258-61. https://doi.org/10.1093/oxfordjournals.humrep.a136280
  23. Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, Ho HN. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod 2008;23:952-7. https://doi.org/10.1093/humrep/den015
  24. Carmina E, Orio F, Palomba S, Longo RA, Lombardi G, Lobo RA. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters. Fertil Steril 2005;84:413-9. https://doi.org/10.1016/j.fertnstert.2004.12.061
  25. Kim JJ, Choi YM. Phenotype and genotype of polycystic ovary syndrome in Asia: ethnic differences. J Obstet Gynaecol Res 2019;45:2330-7. https://doi.org/10.1111/jog.14132
  26. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 2003;18:598-603. https://doi.org/10.1093/humrep/deg115
  27. Kim JJ, Hwang KR, Chae SJ, Yoon SH, Choi YM. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome. Hum Reprod 2020;35:652-9. https://doi.org/10.1093/humrep/deaa012